BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38922553)

  • 1. Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study.
    Zavala-Miranda MF; Sobrino-Vargas AM; Hernández-Andrade A; Caballero-Malacara V; Pérez-Arias AA; Márquez-Macedo SE; Nordmann-Gomes A; Navarro-Sánchez V; Juárez-Cuevas B; Uribe-Uribe NO; Mejia-Vilet JM
    Clin Rheumatol; 2024 Jun; ():. PubMed ID: 38922553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.
    Ravindran A; Casal Moura M; Fervenza FC; Nasr SH; Alexander MP; Fidler ME; Herrera Hernandez LP; Zhang P; Grande JP; Cornell LD; Gross LA; Negron V; Jenson GE; Madden BJ; Charlesworth MC; Sethi S
    J Am Soc Nephrol; 2021 Mar; 32(3):695-706. PubMed ID: 33478971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular Exostosin as a Subtype and Activity Marker of Class 5 Lupus Nephritis.
    Wang C; Liu Y; Zhang M; Yang F; Xu F; Shi S; Zeng C; Chen X; Miao Y; Liu Z; Hu W
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):986-993. PubMed ID: 35584929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis.
    Wada Y; Iyoda M; Suzuki T; Tachibana S; Kanazawa N; Matsumoto K; Honda H
    Virchows Arch; 2021 Nov; 479(5):997-1005. PubMed ID: 34302213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsies.
    Miller PP; Caza T; Larsen CP; Charu V
    Nephrol Dial Transplant; 2023 Feb; 38(2):396-404. PubMed ID: 35278072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.
    Ye T; Jiang M; Zeng X; Zong D; Du Y; Li X; Huang B; Tang X
    Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38154829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Exostosin-Positivity is Associated With Disease Activity and Outcomes in Patients With Membranous Lupus Nephritis.
    Xia X; Li S; Wang Z; Ye S; Fan Y; Peng W; Chen W; Huang F; Tang R; Chen W
    Kidney Int Rep; 2024 Apr; 9(4):1040-1046. PubMed ID: 38765564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of repeated flares in response to therapy and prognosis in lupus nephritis.
    Perez-Arias AA; Márquez-Macedo SE; Pena-Vizcarra OR; Zavala-Miranda MF; Romero-Díaz J; Morales-Buenrostro LE; Mejía-Vilet JM
    Nephrol Dial Transplant; 2023 Mar; 38(4):884-893. PubMed ID: 36318456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Diagnostic and Therapeutic Dilemma Concerning Exostosin 1/Exostosin 2-associated Lupus-like Membranous Nephropathy with Positive Antinuclear Antibody in an Elderly Man with Various Immune Abnormalities.
    Kawagoe M; Odajima K; Asakawa S; Nagura M; Arai S; Yamazaki O; Tamura Y; Ohashi R; Iwakura T; Yasuda H; Shibata S; Fujigaki Y
    Intern Med; 2023 Nov; 62(21):3187-3194. PubMed ID: 36948625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.
    Ahn SS; Yoo J; Lee SW; Song JJ; Park YB; Jung SM
    Lupus; 2022 Apr; 31(5):588-595. PubMed ID: 35316102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis.
    Kwon OC; Park JH; Park HC; Jung SM; Lee SW; Song JJ; Park YB; Park MC
    Arthritis Res Ther; 2020 Jun; 22(1):138. PubMed ID: 32517774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
    Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
    BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renal outcomes of patients with non-proliferative lupus nephritis.
    Kang ES; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Korean J Intern Med; 2023 Sep; 38(5):769-776. PubMed ID: 37545141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
    Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
    J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis.
    Tselios K; Gladman DD; Taheri C; Su J; Urowitz MB
    J Rheumatol; 2021 Feb; 48(2):228-231. PubMed ID: 33259331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus-like membranous nephropathy during the postpartum period expressing glomerular antigens exostosin 1/exostosin 2 and phospholipase A2 receptor: a case report.
    Miyasaka R; Wada Y; Takeuchi K; Abe T; Uchitsubo R; Kawamura S; Sakurabayashi S; Naito S; Aoyama T; Shimizu A; Takeuchi Y
    CEN Case Rep; 2024 Jan; ():. PubMed ID: 38280123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first-year course of urine MCP-1 and its association with response to treatment and long-term kidney prognosis in lupus nephritis.
    Pérez-Arias AA; Méndez-Pérez RA; Cruz C; Zavala-Miranda MF; Romero-Diaz J; Márquez-Macedo SE; Comunidad-Bonilla RA; García-Rueda CC; Mejía-Vilet JM
    Clin Rheumatol; 2023 Jan; 42(1):83-92. PubMed ID: 36107264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
    Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
    Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
    Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.